These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 26808991)

  • 21. Effect of high-dose intracoronary adenosine administration during primary percutaneous coronary intervention in acute myocardial infarction: a randomized controlled trial.
    Fokkema ML; Vlaar PJ; Vogelzang M; Gu YL; Kampinga MA; de Smet BJ; Jessurun GA; Anthonio RL; van den Heuvel AF; Tan ES; Zijlstra F
    Circ Cardiovasc Interv; 2009 Aug; 2(4):323-9. PubMed ID: 20031735
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prospective, Randomized, Multicenter Evaluation of a Polyethylene Terephthalate Micronet Mesh-Covered Stent (MGuard) in ST-Segment Elevation Myocardial Infarction: The MASTER Trial.
    Stone GW; Abizaid A; Silber S; Dizon JM; Merkely B; Costa RA; Kornowski R; Abizaid A; Wojdyła R; Maehara A; Dressler O; Brener SJ; Bar E; Dudek D
    J Am Coll Cardiol; 2012 Nov; 60(19):1975-84. PubMed ID: 23103033
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Rapid resolution of ST segment elevation predicts recovery of left myocardial contraction in patients with acute myocardial infarction treated with percutaneous coronary angioplasty].
    Tomaszuk-Kazberuk A; Korecki J; Kochman W; Dobrzycki S; Musiał WJ
    Przegl Lek; 2002; 59(8):638-41. PubMed ID: 12638338
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prediction of 1-year clinical outcomes using the SYNTAX score in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a substudy of the STRATEGY (Single High-Dose Bolus Tirofiban and Sirolimus-Eluting Stent Versus Abciximab and Bare-Metal Stent in Acute Myocardial Infarction) and MULTISTRATEGY (Multicenter Evaluation of Single High-Dose Bolus Tirofiban Versus Abciximab With Sirolimus-Eluting Stent or Bare-Metal Stent in Acute Myocardial Infarction Study) trials.
    Garg S; Sarno G; Serruys PW; Rodriguez AE; Bolognese L; Anselmi M; De Cesare N; Colangelo S; Moreno R; Gambetti S; Monti M; Bristot L; Bressers M; Garcia-Garcia HM; Parrinello G; Campo G; Valgimigli M;
    JACC Cardiovasc Interv; 2011 Jan; 4(1):66-75. PubMed ID: 21251631
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of outcomes of patients with ST-segment elevation myocardial infarction with versus without previous coronary artery bypass grafting (from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction [HORIZONS-AMI] trial).
    Nikolsky E; Mehran R; Yu J; Witzenbichler B; Brodie BR; Kornowski R; Brener S; Xu K; Dangas GD; Stone GW
    Am J Cardiol; 2013 May; 111(10):1377-86. PubMed ID: 23465098
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical outcomes following stent thrombosis occurring in-hospital versus out-of-hospital: results from the HORIZONS-AMI (Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction) trial.
    Dangas GD; Claessen BE; Mehran R; Brener S; Brodie BR; Dudek D; Witzenbichler B; Peruga JZ; Guagliumi G; Moses JW; Lansky AJ; Xu K; Stone GW
    J Am Coll Cardiol; 2012 May; 59(20):1752-9. PubMed ID: 22575312
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Second-generation everolimus-eluting stents versus first-generation sirolimus-eluting stents in acute myocardial infarction. 1-year results of the randomized XAMI (XienceV Stent vs. Cypher Stent in Primary PCI for Acute Myocardial Infarction) trial.
    Hofma SH; Brouwer J; Velders MA; van't Hof AW; Smits PC; Queré M; de Vries CJ; van Boven AJ
    J Am Coll Cardiol; 2012 Jul; 60(5):381-7. PubMed ID: 22835668
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-Term Outcomes in Survivors of Early Ventricular Arrhythmias After Acute ST-Elevation and Non-ST-Elevation Myocardial Infarction Treated With Percutaneous Coronary Intervention.
    Liang JJ; Fender EA; Cha YM; Lennon RJ; Prasad A; Barsness GW
    Am J Cardiol; 2016 Mar; 117(5):709-13. PubMed ID: 26796195
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Implications of myocardial reperfusion on survival in women versus men with acute myocardial infarction undergoing primary coronary intervention.
    Meller SM; Lansky AJ; Costa RA; Soffler M; Costantini CO; Brodie BR; Cox DA; Stuckey TD; Fahy M; Grines CL; Stone GW
    Am J Cardiol; 2013 Oct; 112(8):1087-92. PubMed ID: 23827398
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pexelizumab and infarct size in patients with acute myocardial infarction undergoing primary percutaneous coronary Intervention: a delayed enhancement cardiac magnetic resonance substudy from the APEX-AMI trial.
    Patel MR; Worthley SG; Stebbins A; Dill T; Rademakers FE; Valeti US; Barsness GW; Van de Werf F; Hamm CW; Armstrong PW; Granger CB; Kim RJ
    JACC Cardiovasc Imaging; 2010 Jan; 3(1):52-60. PubMed ID: 20129531
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of collateral flow on myocardial reperfusion and infarct size in patients undergoing primary angioplasty for acute myocardial infarction.
    Sorajja P; Gersh BJ; Mehran R; Lansky AJ; Krucoff MW; Webb J; Cox DA; Brodie BR; Stone GW
    Am Heart J; 2007 Aug; 154(2):379-84. PubMed ID: 17643592
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship between myocardial reperfusion, infarct size, and mortality: the INFUSE-AMI (Intracoronary Abciximab and Aspiration Thrombectomy in Patients With Large Anterior Myocardial Infarction) trial.
    Brener SJ; Maehara A; Dizon JM; Fahy M; Witzenbichler B; Parise H; El-Omar M; Dambrink JH; Mehran R; Oldroyd K; Gibson CM; Stone GW
    JACC Cardiovasc Interv; 2013 Jul; 6(7):718-24. PubMed ID: 23866184
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sex-related Impact on Clinical Outcome of Everolimus-eluting Versus Bare-metal Stents in ST-segment Myocardial Infarction. Insights From the EXAMINATION Trial.
    Regueiro A; Fernández-Rodríguez D; Brugaletta S; Martín-Yuste V; Masotti M; Freixa X; Cequier Á; Íñiguez A; Serruys PW; Sabaté M;
    Rev Esp Cardiol (Engl Ed); 2015 May; 68(5):382-9. PubMed ID: 25444377
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Five-year clinical outcome of titanium-nitride-oxide-coated bioactive stents versus paclitaxel-eluting stents in patients with acute myocardial infarction: long-term follow-up from the TITAX AMI trial.
    Tuomainen PO; Ylitalo A; Niemelä M; Kervinen K; Pietilä M; Sia J; Nyman K; Nammas W; Airaksinen KE; Karjalainen PP
    Int J Cardiol; 2013 Sep; 168(2):1214-9. PubMed ID: 23218575
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relation of gender to infarct size in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty.
    De Luca G; Parodi G; Sciagrà R; Bellandi B; Verdoia M; Vergara R; Migliorini A; Valenti R; Antoniucci D
    Am J Cardiol; 2013 Apr; 111(7):936-40. PubMed ID: 23332594
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gender and myocardial salvage after reperfusion treatment in acute myocardial infarction.
    Mehilli J; Ndrepepa G; Kastrati A; Nekolla SG; Markwardt C; Bollwein H; Pache J; Martinoff S; Dirschinger J; Schwaiger M; Schömig A
    J Am Coll Cardiol; 2005 Mar; 45(6):828-31. PubMed ID: 15766814
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mesh-covered embolic protection stent implantation in ST-segment-elevation myocardial infarction: final 1-year clinical and angiographic results from the MGUARD for acute ST elevation reperfusion trial.
    Dudek D; Dziewierz A; Brener SJ; Abizaid A; Merkely B; Costa RA; Bar E; Rakowski T; Kornowski R; Dressler O; Abizaid A; Silber S; Stone GW
    Circ Cardiovasc Interv; 2015 Feb; 8(2):e001484. PubMed ID: 25603802
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety and efficacy of high- versus low-dose aspirin after primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial.
    Yu J; Mehran R; Dangas GD; Claessen BE; Baber U; Xu K; Parise H; Fahy M; Lansky AJ; Witzenbichler B; Grines CL; Guagliumi G; Kornowski R; Wöhrle J; Dudek D; Weisz G; Stone GW
    JACC Cardiovasc Interv; 2012 Dec; 5(12):1231-8. PubMed ID: 23257371
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of infarct-related artery patency before primary PCI on outcome in patients with ST-segment elevation myocardial infarction: the HORIZONS-AMI trial.
    Rakowski T; Dudek D; Dziewierz A; Yu J; Witzenbichler B; Guagliumi G; Kornowski R; Hartmann F; Lansky AJ; Brener SJ; Mehran R; Stone GW
    EuroIntervention; 2013 Mar; 8(11):1307-14. PubMed ID: 23538158
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical and angiographic characteristics of patients with combined anterior and inferior ST-segment elevation on the initial electrocardiogram during acute myocardial infarction.
    Sadanandan S; Hochman JS; Kolodziej A; Criger DA; Ross A; Selvester R; Wagner GS
    Am Heart J; 2003 Oct; 146(4):653-61. PubMed ID: 14564319
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.